Skip Navigation

Cardiovascular Research 2001 51(3):442-449; doi:10.1016/S0008-6363(01)00195-X
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boomsma, F.
Right arrow Articles by van den Meiracker, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boomsma, F.
Right arrow Articles by van den Meiracker, A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use

Frans Boomsma* and Anton H. van den Meiracker

Internal Medicine/Cardiovascular Research Institute COEUR, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands

* Corresponding author. University Hospital Dijkzigt, Internal Medicine, Rm L-276, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Tel.: +31-10-463-3764; fax: +31-10-463-4531 boomsma@inw1.azr.nl

Received 17 November 2000; accepted 20 December 2000

KEYWORDS Natriuretic peptide; Atrial function; Ventricular function

The first 150 words of the full text of this article appear below.


   1 Introduction
 
In the 20 years which have passed since the first description by de Bold of a natriuretic and diuretic substance produced in the heart [1], a large body of research has firmly established the position of the heart as an endocrine organ. Two peptides, both containing a 17-amino acid ring structure, have been a focus of much interest: atrial natriuretic peptide (ANP), and brain (or B-type) natriuretic peptide (BNP). A third member of this family of peptides, C-type natriuretic peptide, has been described; it is mainly produced by the endothelium and not by the heart, has no diuretic or natriuretic activity, and will not be discussed here.

ANP is produced mainly in the cardiac atria, while BNP, originally isolated from porcine brain, was soon reported to be mainly produced in the cardiac ventricles. In recent years, however, it has become clear that in fact both ANP and BNP are . . . [Full Text of this Article]


   2 Physiological effects of ANP and BNP
 

   3 Methodology
 
3.1 Blood sampling conditions
3.2 Measurement
3.3 Stability

   4 Use of natriuretic peptide measurements
 
4.1 Congestive heart failure (CHF)
4.2 Acute coronary syndromes
4.3 Right ventricular overload
4.4 Renal failure
4.5 Hypertension

   5 Pharmacological manipulation
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
K. K. Gaddam, M. K. Nishizaka, M. N. Pratt-Ubunama, E. Pimenta, I. Aban, S. Oparil, and D. A. Calhoun
Characterization of Resistant Hypertension: Association Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume Expansion
Arch Intern Med, June 9, 2008; 168(11): 1159 - 1164.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
H. Kataoka and O. Matsuno
Age-Related Pulmonary Crackles (Rales) in Asymptomatic Cardiovascular Patients
Ann. Fam. Med, May 1, 2008; 6(3): 239 - 245.
[Abstract] [Full Text] [PDF]